Collectively, our results provide a new perspective that the pseudogene-derived lncRNA DUXAP8 may act as a noncoding oncogene in GC tumorigenesis and could be a novel target for the early diagnosis and treatment of GC. Here, DUXAP8 is linked to gastric cancer.